Dr. Reddy's Recalls Sapropterin Dihydrochloride Powder For Oral Solution

RTTNews | 557日前
Dr. Reddy's Recalls Sapropterin Dihydrochloride Powder For Oral Solution

(RTTNews) - Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level.

According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

The product is indicated to reduce blood phenylalanine (Phe) levels in adult and pediatric patients one month of age and older with hyperphenylalaninemia or HPA due to tetrahydrobiopterin-(BH4-) responsive Phenylketonuria (PKU).

Reduced efficacy of the product would result in elevated Phenylalaninemia or Phe levels in patients. Chronically elevated Phe levels in infants and children may cause permanent neurocognitive deficits, and elevated Phe levels during pregnancy, especially in early gestation, are associated with microcephaly and congenital heart disease.

The issue was discovered during an accelerated stability test in addition to customer complaints.

However, Dr. Reddy's has not received any reports of adverse events related to the recall so far.

The impacted drug is packaged in individual packets, 30 per carton. The affected drugs include Javygtor Powder for Oral Solution 100 mg with lot mumbers T2202812, T2204053, T2300975, T2300976, and T2304356; as well as Sapropterin Dihydrochloride Powder for Oral Solution 100 mg with lot code T2200352.

The product was distributed nationwide to wholesalers/retailers.

Dr. Reddy's is notifying its distributors and customers and is arranging for returns of all recalled products.

For More Such Health News, visit rttnews.com

read more
Dr. Reddy's Labs Recalls Levetiracetam In Sodium Chloride Injection

Dr. Reddy's Labs Recalls Levetiracetam In Sodium Chloride Injection

Dr. Reddy's Laboratories Ltd. is recalling Levetiracetam in 0.75% Sodium Chloride Injection in the United States citing mislabeling of infusion bag, according to the U.S. Food and Drug Administration. The recall involves one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL (10 mg/mL) single-dose infusion bags to the consumer level.
RTTNews | 234日前
Taiwan Manufacturing PMI Ticks Higher In October

Taiwan Manufacturing PMI Ticks Higher In October

The manufacturing sector in Taiwan continued to contract in October, albeit at a slower rate, the latest survey from S&P Global revealed on Monday with a manufacturing PMI score of 47.7.
RTTNews | 1時8分前
South Korea PMI Sinks In October - S&P Global

South Korea PMI Sinks In October - S&P Global

The manufacturing sector in South Korea fell into contraction territory in October, the latest survey from S&P Global revealed on Monday with a Performance of Manufacturing Index score of 49.4.
RTTNews | 1時10分前
China Stock Market May Stop The Bleeding On Monday

China Stock Market May Stop The Bleeding On Monday

The China stock market has finished lower in back-to-back sessions, slipping more than 60 points or 1.5 percent along the way. The Shanghai Composite Index now sits just above the 3,950-point plateau, although it's due for support on Monday.
RTTNews | 1時13分前
Australian Market Notably Lower

Australian Market Notably Lower

The Australian stock market is notably lower on Monday, adding the losses in the previous four sessions, despite the broadly positive cues from Wall Street on Friday. The benchmark S&P/ASX 200 index is falling below the 8,850.00 level, with weakness in gold miners and financial stocks partially offset by gains in iron ore miners, energy and technology stocks.
RTTNews | 1時22分前